603882 金域医学
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.654-2.465-4.8607.57136.885
总资产报酬率 ROA (%)0.455-1.733-3.4415.01522.357
投入资产回报率 ROIC (%)0.573-2.192-4.4246.97533.452

边际利润分析
销售毛利率 (%)34.89634.74133.14636.47843.128
营业利润率 (%)4.905-2.154-3.8018.89721.628
息税前利润/营业总收入 (%)4.603-3.074-6.1408.65721.376
净利润/营业总收入 (%)3.544-2.962-5.7687.45818.383

收益指标分析
经营活动净收益/利润总额(%)96.528-118.996-100.489122.168106.417
价值变动净收益/利润总额(%)-10.420-0.94415.47535.522-0.325
营业外收支净额/利润总额(%)-8.50928.49037.707-2.631-0.798

偿债能力分析
流动比率 (X)3.1283.2383.2783.0732.327
速动比率 (X)3.0363.1473.1892.9812.239
资产负债率 (%)29.53628.59028.06827.36536.104
带息债务/全部投入资本 (%)10.87110.3598.1214.9664.747
股东权益/带息债务 (%)800.966849.2021,105.7561,855.2511,940.682
股东权益/负债合计 (%)233.634245.063251.139259.693172.122
利息保障倍数 (X)55.79649.386159.115-701.395-263.228

营运能力分析
应收账款周转天数 (天)224.626231.274243.646260.537135.972
存货周转天数 (天)18.86617.58316.72221.68415.346